Latest stories on ORIC
ORIC Pharmaceuticals: Royalty-Free Phase 3 Economics Strengthen The Bull Case
Seeking Alpha73 · bullishproduct/pr
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News
StockTitan50 · neutralgeneral
Oric Pharmaceuticals, Inc. (ORIC) files 8-K
SEC 8-K50 · neutralgeneral
ORIC gains as Stifel resumes at Buy on upcoming Pfizer readout
Seeking Alpha63 · neutralanalyst
ORIC Pharmaceuticals, Inc. (ORIC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News
StockTitan50 · neutralgeneral
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences | ORIC Stock News
StockTitan56 · neutralgeneral